OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
January 15, 2021
The fill line will work to manufacture high-value APIs for drug product manufacturing to meet the needs of the COVID-19 pandemic.
January 03, 2021
Consider a matrix of factors when choosing what type of cleanroom facility to construct.
December 09, 2020
The company is investing in expansion at four sites in the United States, United Kingdom, and Italy, which will include construction of new facilities and addition of sterile and lyophilized filling lines.
December 01, 2020
A holistic approach to validation and quality assurance is essential.
November 03, 2020
An optimal engineering design is crucial for aseptic operation and cleaning.
November 02, 2020
Assessing the integrity of filter membranes is critical for maintaining sterile filtration operations in laboratories.
September 09, 2020
The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes.
September 02, 2020
Dimethyl sulfoxide is increasingly used in high-risk parenteral and medical device applications that must be manufactured as sterile products in their finished form. A study evaluated the effects four sterilization techniques have on the product quality of this ingredient.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
July 06, 2020
The agreement will combine Rentschler’s experience in drug substance manufacturing and Vetter’s expertise in aseptic fill/finish and secondary packaging.